| Literature DB >> 28013261 |
Grace D Appiah1,2, Sandra S Chaves3, Pam D Kirley2, Lisa Miller4, James Meek5, Evan Anderson6, Oluwakemi Oni7, Patricia Ryan8, Seth Eckel9, Ruth Lynfield10, Marisa Bargsten11, Shelley M Zansky12, Nancy Bennett3, Krista Lung13, Christie McDonald-Hamm14, Ann Thomas15, Diane Brady16, Mary L Lindegren17, William Schaffner17, Mary Hill18, Shikha Garg3, Alicia M Fry3, Angela P Campbell19.
Abstract
(See the Editorial Commentary by Martin on pages 368-9.)Using population-based surveillance data, we analyzed antiviral treatment among hospitalized patients with laboratory-confirmed influenza. Treatment increased after the influenza A(H1N1) 2009 pandemic from 72% in 2010-2011 to 89% in 2014-2015 (P < .001). Overall, treatment was higher in adults (86%) than in children (72%); only 56% of cases received antivirals on the day of admission.Entities:
Keywords: antiviral; influenza; oseltamivir.
Mesh:
Substances:
Year: 2016 PMID: 28013261 PMCID: PMC5480237 DOI: 10.1093/cid/ciw745
Source DB: PubMed Journal: Clin Infect Dis ISSN: 1058-4838 Impact factor: 9.079